Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

| More on:
A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Macquarie is bullish on a supermarket giant, citing successful market share expansion and strong sales growth, leading to an outperform rating and increased price target.
  • A biotech leader is seen as undervalued by Morgans, which maintains a buy rating despite a recent guidance downgrade, highlighting a buying opportunity due to low earnings multiples.
  • Macquarie's positive view on a buy now pay later provider is driven by its rapid growth and potential in the US market, resulting in a new coverage with a favorable price target.

It was another busy week for Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:

Coles Group Ltd (ASX: COL)

According to a note out of the Macquarie equities desk, its analysts have retained their outperform rating on this supermarket giant's shares with an improved price target of $26.10. The broker was pleased with Coles' first quarter update and notes that its sales growth outperformed its main rival. This suggests that its market share gains have continued. And with Coles appearing to be retaining its new shoppers, Macquarie believe it is well-placed to deliver strong earnings growth in the next three years. As a result, it thinks its shares are good value at current levels. The Coles share price ended the week at $22.05.

CSL Ltd (ASX: CSL)

A note out of Morgans reveals that its analysts have retained their buy rating on this biotech giant's shares with a reduced price target of $249.51. Although the broker concedes that CSL's guidance downgrade was disappointing and it remains unclear when US influenza vaccination rates will stabilise, it thinks the share price selldown has been severely overdone. As a result, Morgans believes that its shares are trading on unjustifiably low earnings multiples at present and is recommending investors buy the dip. The CSL share price was fetching $178.50 at Friday's close.

Zip Co Ltd (ASX: ZIP)

Another note out of Macquarie reveals that its analysts have initiated coverage on this buy now pay later provider's shares with a $4.85 price target. According to the note, the broker believes that Zip is an attractive investment option for Aussie investors thanks partly to its US segment. It highlights that this side of the business is currently outpacing peers. And despite US total transaction value (TTV) growing >40% annually, it still has a significant opportunity to acquire new customers in an underserved market. In light of this, it is forecasting Zip to continue to deliver rapid growth in the coming years. This will be supported by increased product adoption, expansion of merchant network, increased customer engagement, and digital product innovation. The Zip share price ended the week at $3.87.

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Two people comparing and analysing material.
Broker Notes

Buy, hold, sell: Netwealth, Santos, and South32 shares

Morgans has given its verdict on these shares following updates.

Read more »

Business man at desk looking out window with his arms behind his head at a view of the city and stock trends overlay.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Three smiling corporate people examine a model of a new building complex.
Broker Notes

Broker says this ASX All Ords stock could rise 15%

Bell Potter thinks investors should be buying this growing company's shares.

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Broker Notes

Why Lynas shares could crash 33%

Bell Potter believes this rare earths stock could lose a third of its value.

Read more »

Three girls compete in a race, running fast around an athletic track.
Broker Notes

Two ASX 200 stocks to buy after crashing 6-9% yesterday

Bell Potter is tipping an 18-40% resurgence for these stocks.

Read more »

A woman looks quizzical as she looks at a graph of the share market.
Broker Notes

Looking for double-digit returns? Check out RBC Capital Markets' picks ahead of reporting season

These shares could deliver strong upside.

Read more »

Man controlling a drone in the sky.
Broker Notes

ASX defence stocks to target according to Bell Potter

The bull run might not be finished yet for these two companies.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

What is Morgans saying about ARB and BHP shares?

Is now the time to buy these popular shares? Let's find out.

Read more »